Artificial pancreas improves condition of type 1 diabetes patient

11/7/2013 | Bloomberg

A fully automated artificial pancreas has offered new hope for Thomas Brobson, a 53-year-old patient with type 1 diabetes. The experimental device involves a computer algorithm that connects to a glucose sensor and an insulin pump that interface with each other to mimic a healthy pancreas. Similar devices are being developed by companies such as Johnson & Johnson and Medtronic. After receiving the device last year as part of a three-day trial, Brobson said he slept soundly through the night without worries that his blood sugar would dip too low. "I felt like I was getting a glimpse of what a cure would be like," he said.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ